coiaward2010

CML Support Groups: Members of the CML Advocates Network

The CML Advocates Network connects patient organisations supporting patients and families affected with Chronic Myeloid Leukemia (CML)

If your group is not listed here, please register. If details have changed, please contact us.

Indonesia: Indonesian CML & GIST Community (ELGEKA Indonesia)

CONTACT INFORMATION:

Mailing/Postal Address:

Indonesian CML & GIST Community (ELGEKA Indonesia)

Sarinah Building, 11th Floor
M.H. Thamrin Street, No. 11
Jakarta - Indonesia 10350


Telephone: +62213146542
Fax: +62213146543
Website:elgekajawabarat.wordpress.com

EMail:

 

KEY CONTACT:

Name: Andrian Rakhmatsyah
Position: Secretary General

 

KEY OBJECTIVES & INITIATIVES:

Indonesian CML and GIST Community is a forum for patients with CML and Gastrointestinal Stromal Tumor (GIST) and Care Giver either to the patient or the disease.
 

BRIEF DESCRIPTION OF ORGANIZATION:

Being a good CML and GIST organization and care for the needs of members toward healthy and unyielding spirit.

Our mission,
1. Facilitate members participated in the program
2. Establish and improve harmonius relations between members, physicians, organization, goverments, and International organization alike
3. Increasing knowledge and provides actual information about CML & GIST to members
4. Provide information to general public about CML & GIST, and help new patients as a member of the organization.

 

NUMBER OF MEMBERS:

1.900 throughout Indonesia (by March 2015)

 

COUNTRIES IN WHICH ORGANIZATION HAS A SIGNIFICANT MEMBERSHIP BASE:

Indonesia


 
   
 

EU e-Privacy Directive

Please donate!

Please donate!

Tweet Feed

cmlnet
Check our global database run by patients for #patients with 51 current #CML #clinicaltrials which have been initia… twitter.com/i/web/status/9…

Thursday, 24 May 2018

ZPWLC
“When looking at statistics, it is important to remember that we are not talking about decimal points on a graph, b… twitter.com/i/web/status/9…

Retweeted Thursday, 24 May 2018

LMC_PACIENTES
From 26 April “Sprycel is indicated for the treatment of paediatric patients with: newly diagnosed Ph+ CML in chron… twitter.com/i/web/status/9…

Retweeted Saturday, 19 May 2018